Increased sensitivity to TRAIL-induced apoptosis occurs during the adenoma to carcinoma transition of colorectal carcinogenesis.
about
The Janus Face of Death Receptor Signaling during Tumor ImmunoeditingInteraction of dietary fatty acids with tumour necrosis factor family cytokines during colon inflammation and cancer.Selective BRAFV600E inhibitor PLX4720, requires TRAIL assistance to overcome oncogenic PIK3CA resistance.Prognostic significance of TRAIL death receptors in Middle Eastern colorectal carcinomas and their correlation to oncogenic KRAS alterationsA genome-wide scan of 10 000 gene-centric variants and colorectal cancer riskIAP antagonists Birinapant and AT-406 efficiently synergise with either TRAIL, BRAF, or BCL-2 inhibitors to sensitise BRAFV600E colorectal tumour cells to apoptosis.Newly established tumourigenic primary human colon cancer cell lines are sensitive to TRAIL-induced apoptosis in vitro and in vivo.Is there a genetic signature for liver metastasis in colorectal cancer?Death receptor 5 (DR5) and a 5-gene apoptotic biomarker panel with significant differential diagnostic potential in colorectal cancer.Cell death pathways--potential therapeutic targets.Update on novel monoclonal antibodies and immunoconjugates for the treatment of lymphoproliferative disorders.Targeting FLIP and Mcl-1 using a combination of aspirin and sorafenib sensitizes colon cancer cells to TRAIL.Human Organ Culture: Updating the Approach to Bridge the Gap from In Vitro to In Vivo in Inflammation, Cancer, and Stem Cell Biology.TNF-related apoptosis-inducing ligand cooperates with NSAIDs via activated Wnt signalling in (pre)malignant colon cells.
P2860
Q28070036-10011A54-F981-4D4B-9519-A578D969BB5CQ33614335-402BEF89-DB52-453D-BB0E-E6957C795501Q33955186-6763D831-879B-4548-B4BB-842B87D7E1BEQ34068205-332FBBC4-6D4C-419D-9AA7-0847FCABC3BDQ34327333-0939ADE6-7250-4401-8A42-F6533A73D1CAQ36103378-674E28AD-C483-4B86-B674-D56BDD40E514Q36608654-4F6EF962-9E63-4D99-B788-97EACFD4D9D4Q36996320-0BB3C425-595D-45DA-94F7-E21B7BA2A88CQ37402581-1DE87714-EAAC-4C96-9D65-C4846B9F3BC8Q37557634-3C532AA1-FFB0-423C-B018-A570B6F18780Q37913356-BADAAA7E-AAE7-41D3-9A3A-A03EC45B1779Q39248620-61187661-67A8-4619-9B39-D72ECC56E24BQ41684168-3E66CE1E-FEDB-4D5B-9AF8-681746E22FF5Q42775674-3EA32398-2FC4-4A19-A76B-C845FE085E6D
P2860
Increased sensitivity to TRAIL-induced apoptosis occurs during the adenoma to carcinoma transition of colorectal carcinogenesis.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Increased sensitivity to TRAIL ...... of colorectal carcinogenesis.
@en
type
label
Increased sensitivity to TRAIL ...... of colorectal carcinogenesis.
@en
prefLabel
Increased sensitivity to TRAIL ...... of colorectal carcinogenesis.
@en
P2093
P2860
P356
P1476
Increased sensitivity to TRAIL ...... of colorectal carcinogenesis.
@en
P2093
C Paraskeva
M MacFarlane
P2860
P2888
P304
P356
10.1038/SJ.BJC.6602387
P407
P577
2005-02-01T00:00:00Z